AWC
IBRX icon

Abundance Wealth Counselors’s ImmunityBio IBRX Stock Holding History

Abundance Wealth Counselors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.5K Buy
+10,111
New +$76.5K 0.01% 310

Other funds holding IBRX

SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $489M AUM 21.64% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Abundance Wealth Counselors's IBRX Position: Q2 2026 in Review

Abundance Wealth Counselors opened a new position in ImmunityBio (IBRX) in Q2 2026: 10,111 shares worth $88.5K. The stake represents 0.01% of the portfolio and ranks #310 among its holdings.

81 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Abundance Wealth Counselors held 10,111 shares of ImmunityBio worth $88.5K as of Q2 2026.
  • ImmunityBio was a new Abundance Wealth Counselors position in Q2 2026.
  • ImmunityBio made up 0.01% of Abundance Wealth Counselors's portfolio in Q2 2026, its #310 holding.
  • 81 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.